Literature DB >> 15187251

Cell cycle checkpoint control mechanisms that can be disrupted in cancer.

Bipin C Dash1, Wafik S El-Deiry.   

Abstract

Maintenance of genomic integrity is essential to avoid cellular transformation, neoplasia, or cell death. DNA synthesis, mitosis, and cytokinesis are important cellular processes required for cell division and the maintenance of cellular homeostasis; they are governed by many extra- and intra-cellular stimuli. Progression of normal cell division depends on cyclin interaction with cyclin-dependent kinases (Cdk) and the degradation of cyclins before chromosomal segregation through ubiquitination. Multiple checkpoints exist and are conserved in the cell cycle in higher eukaryotes to ensure that if one fails, others will take care of genomic integrity and cell survival. Many genes act as either positive or negative regulators of checkpoint function through different kinase cascades, delaying cell cycle progression to repair the DNA lesions and breaks, and assuring equal segregation of chromosomes to daughter cells. Understanding the checkpoint pathways and genes involved in the cellular response to DNA damage and cell division events in normal and cancer cells, provides information about cancer predisposition, and suggests design of small molecules and other strategies for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187251     DOI: 10.1385/1-59259-788-2:099

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

2.  Transcriptional landscape of the human cell cycle.

Authors:  Yin Liu; Sujun Chen; Su Wang; Fraser Soares; Martin Fischer; Feilong Meng; Zhou Du; Charles Lin; Clifford Meyer; James A DeCaprio; Myles Brown; X Shirley Liu; Housheng Hansen He
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

Review 3.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

Review 4.  Human T-cell leukemia virus type 1 Tax and cellular transformation.

Authors:  Jean-Marie Peloponese; Takao Kinjo; Kuan-Teh Jeang
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

5.  The replication stress response and the ubiquitin system: a new link in maintaining genomic integrity.

Authors:  Deanna M Koepp
Journal:  Cell Div       Date:  2010-03-10       Impact factor: 5.130

6.  Multiple functions of rad9 for preserving genomic integrity.

Authors:  Kazuhiro Ishikawa; Hideshi Ishii; Toshiyuki Saito; Keiichi Ichimura
Journal:  Curr Genomics       Date:  2006       Impact factor: 2.236

7.  A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.

Authors:  Surojit Sur; Raymond Pagliarini; Fred Bunz; Carlo Rago; Luis A Diaz; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

8.  Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis.

Authors:  Claire M Payne; Carol Bernstein; Katerina Dvorak; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2008-12-16

9.  Cordyceps militaris Grown on Germinated Soybean Induces G2/M Cell Cycle Arrest through Downregulation of Cyclin B1 and Cdc25c in Human Colon Cancer HT-29 Cells.

Authors:  Mohammad Lalmoddin Mollah; Dong Ki Park; Hye-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-12       Impact factor: 2.629

10.  p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.

Authors:  Carmela Ciccarelli; Francesco Marampon; Arianna Scoglio; Annunziata Mauro; Cristina Giacinti; Paola De Cesaris; Bianca M Zani
Journal:  Mol Cancer       Date:  2005-12-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.